leftspacer middlespacer rightspacer
Media Menu
Featured Material


MAPS BULLETIN
MAPS Bulletin Spring 2014: Special Edition: Psychedelics and Education
 
Media > Recent and Archival
June 6, 2014

Do Psychedelics Have a Place in the Future of Medicine?

By: Michael Phillip

Midwest Real

Midwest Real interviews Brad Burge of MAPS and retired Army Ranger Tim Amoroso about clinical research and anecdotal testimonials suggesting that the therapeutic use of psychedelics can provide profound healing for people suffering from a variety of conditions. The group discusses current research into the medical potential of various psychedelics, the best approaches to pursuing a career in the field of psychedelics, the value of the internet and social media for providing psychedelic education, and future research that can lead to FDA-approval for prescription use of MDMA-assisted psychotherapy.


Listen to the interview here.

It seems we’re finally at a turning point in The War on Drugs.  All it took was a few decades of indoctrination, mass-incarceration, astronomical price tags and straight-up horrific body counts. Yet, society’s transition into a deeper understanding of these substances has been far from smooth. Yes, the people have clearly spoken on the subject of marijuana, and nearly half of all U.S. states have taken notice, putting some sort of marijuana-friendly law on the books. However, when it comes to Mary Jane’s more potent psychedelic cousins, the conversation is quite a bit more nuanced and controversial. Thankfully, for the first time in decades, the dialogue surrounding psychedelics is evolving. For that, we have organizations like MAPS to thank.

As your eyeballs wiggle their way through these words, MAPS (The Multidisciplinary Association for Psychedelic Studies) is in the process of conducting a whole host of FDA-sanctioned studies using psychedelic substances on real-live human beings. The therapeutic use of MDMA, for example, has been shown to be a highly effective treatment for PTSD. A slow-clap-worthy 83 percent of participants were, in fact, totally PTSD free at their two month follow-up exams.

While these developments are genuinely encouraging, the bleak fact of the matter is that psychedelic therapies are still a long way from legal, meaning very few of those in need are actually receiving these potentially highly potent treatments.

To dig further into this, I spoke with Brad Burge of MAPS along with three-tour Army Ranger veteran and psychedelic success story, Tim Amoroso.


Back to MAPS in the Media

Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.